Context Therapeutics (CNTX) Current Leases (2022 - 2026)
Context Therapeutics (CNTX) posted Current Leases of $160055.0 for Q1 2026, up 42.82% sequentially from $112064.0 in Q4 2025, and up 44.07% YoY from $111098.0 in Q1 2025.
Context Therapeutics (CNTX) Current Leases (2022 - 2026) Analysis & Trends
Context Therapeutics has reported Current Leases for 5 years, with the latest figure at $160055.0 in Q1 2026.
- Quarterly Current Leases rose 44.07% year-over-year to $160055.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $160055.0 (up 44.07% YoY) and the FY2025 annual result came in at $112064.0, up 4.42% from the prior year.
- Current Leases advanced to $160055.0 in Q1 2026 per CNTX's latest filing, from $112064.0 in the prior quarter.
- Over five years, Current Leases peaked at $160055.0 in Q1 2026 and troughed at $7967.0 in Q2 2023.
- A 5-year average of $91272.2 and a median of $104160.0 in 2024 frame the typical range for Current Leases.
- The sharpest annual moves came in 2023 and 2026: Current Leases sank 91.44% in 2023, then surged 44.07% in 2026.
- Over 5 years, Current Leases stood at $55078.0 in 2022, then slumped by 85.54% to $7967.0 in 2023, then surged by 1247.01% to $107316.0 in 2024, then grew by 4.42% to $112064.0 in 2025, then jumped by 42.82% to $160055.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $160055.0, $112064.0, and $118980.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.65 Bn | 131.79 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.08 Bn | 78.09 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.16 Bn | 59.98 Bn | 1.37 Bn | - |
| 4 | Moderna | 63.25 Bn | 58.11 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.26 Bn | 27.95 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.96 Bn | 10.57 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.19 Bn | 26.35 Bn | - | - |
| 10 | Context Therapeutics | 50.51 Mn | 50.51 Mn | - | 167,468.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 167,468.00 |
| Mar 31, 2026 | 160,055.00 |
| Dec 31, 2025 | 112,064.00 |
| Sep 30, 2025 | 118,980.00 |
| Jun 30, 2025 | 114,985.00 |
| Mar 31, 2025 | 111,098.00 |
| Dec 31, 2024 | 107,316.00 |
| Sep 30, 2024 | 104,160.00 |
| Jun 30, 2023 | 7,967.00 |
| Mar 31, 2023 | 31,669.00 |
| Dec 31, 2022 | 55,078.00 |
| Sep 30, 2022 | 78,197.00 |
| Jun 30, 2022 | 93,062.00 |
| Mar 31, 2022 | 91,908.00 |